Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel

DA Jabs, JT Rosenbaum, CS Foster… - American journal of …, 2000 - Elsevier
PURPOSE: To provide recommendations for the use of immunosuppressive drugs in the
treatment of patients with ocular inflammatory disorders. PARTICIPANTS: A 12-person panel of …

[HTML][HTML] Summary of the II international symposium on cytomegalovirus

…, GJ Galasso, B Gazzard, PD Griffiths, DA Jabs… - Antiviral research, 1998 - Elsevier
Human cytomegalovirus (HCMV) is a highly species-specific DNA virus belonging to the
Betaherpesvirinae subfamily of the herpesviridae family. Like other herpesviruses, primary …

Clinical features and associated systemic diseases of HLA-B27 uveitis

…, JP Dunn, DM Meisler, S Vitale, DA Jabs - American journal of …, 1996 - Elsevier
Purpose To delineate the clinical features, course, complications, and associated systemic
diseases in patients with HLA-B27-associated uveitis. Methods We reviewed the records of …

[HTML][HTML] Paraneoplastic pemphigus: an autoimmune mucocutaneous disease associated with neoplasia

…, JR Stanley, NJ Korman, DA Jabs… - … England Journal of …, 1990 - Mass Medical Soc
Background and Methods. We describe five patients with underlying neoplasms in whom
painful mucosal ulcerations and polymorphous skin lesions developed, usually with …

[HTML][HTML] Early outpatient treatment for Covid-19 with convalescent plasma

…, N Karlen, A Singh, DE Ford, DA Jabs… - … England Journal of …, 2022 - Mass Medical Soc
Background Polyclonal convalescent plasma may be obtained from donors who have
recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing …

Expert panel recommendations for the use of anti–tumor necrosis factor biologic agents in patients with ocular inflammatory disorders

G Levy-Clarke, DA Jabs, RW Read, JT Rosenbaum… - Ophthalmology, 2014 - Elsevier
Topic To provide recommendations for the use of anti-tumor necrosis factor α (TNF-α)
biologic agents in patients with ocular inflammatory disorders. Clinical Relevance Ocular …

Gut epithelial barrier dysfunction and innate immune activation predict mortality in treated HIV infection

…, CL Meinert, ML Van Natta, DA Jabs… - The Journal of …, 2014 - academic.oup.com
Background. While inflammation predicts mortality in treated human immunodeficiency virus
(HIV) infection, the prognostic significance of gut barrier dysfunction and phenotypic T-cell …

Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease

…, RD Levinson, GN Holland, DA Jabs… - Arthritis Care & …, 2001 - Wiley Online Library
Objective To evaluate the clinical usefulness of tumor necrosis factor (TNF) inhibitors in
patients with inflammatory eye disease that is resistant to conventional immunosuppressive …

[HTML][HTML] Episcleritis and scleritis: clinical features and treatment results

DA Jabs, A Mudun, JP Dunn, MJ Marsh - American journal of …, 2000 - Elsevier
PURPOSE: To evaluate the clinical experience with episcleritis and scleritis at a tertiary
care eye center. METHODS: Retrospective chart review. RESULTS: One hundred thirty-four …

Ocular involvement in chronic sarcoidosis

DA Jabs, CJ Johns - American journal of ophthalmology, 1986 - Elsevier
Although spontaneous remissions often occur in sarcoidosis, chronic persistent disabling
disease is also observed. Of a series of 183 patients with chronic sarcoidosis, 47 (26%) had …